29 completed, 9 unknown, 6 terminated, 5 recruiting. 56 Phase 2, 17 Phase 3, 6 Phase 1.
Follow nitazoxanide: new trials by email Literature Review of nitazoxanide trials Research Report on nitazoxanide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nitazoxanide in Spontaneous Bacterial Peritonitis Nitazoxanide (NTZ), Placebo - SBP - Spontaneous Bacterial Peritonitis | Phase 1 / Phase 2 | Recruiting | Tanta University | 60 | 2026-10-25 | 2026-10-30 |
| Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis Nitazoxanide (NTZ) - Ulcerative Colitis (UC) | Phase 2 / Phase 3 | Recruiting | Tanta University | 44 | 2026-10-25 | 2026-11-09 |
| Phase 2 Study of 500 mg BID NTZ on Top of Standard of Care in Patients With Acute Decompensation of Liver Cirrhosis at High Risk of Progression to Acute-on-Chronic Liver Failure or Established Acute-on-Chronic Liver Failure NTZ 500mg BID on top of SOC - Acute Decompensation of Liver Cirrhosis, Established Acute-on-Chronic Liver Failure | Phase 2 | Not yet recruiting | Genfit | 16 | 2026-10-01 | 2026-07-09 |
| A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHD Fecal Microbiota Transplant (FMT), Nitazoxanide 500mg BID, Vancomycin 250mg BID - ADHD, ADHD - Attention Deficit Disorder With Hyperactivity | Phase 2 | Not yet recruiting | University of Calgary | 64 | 2026-08-31 | 2026-09-10 |
| Nitazoxanide in Patients With Ulcerative Colitis Mesalamine, Nitazoxanide - Ulcerative Colitis | Phase 2 | Recruiting | Alexandria University | 70 | 2025-05-30 | 2025-06-27 |
| Nitazoxanide vs Metronidazole for Entamoeba Diarrhea in Children Nitazoxanide, Metronidazole - Entamoeba Histolytica Diarrhea | Phase 2 | Completed | University of Child Health Sciences and Children's Hospital, Lahore | 90 | 2024-04-02 | 2026-08-27 |
| Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus Nitazoxanide - Diabetes Mellitus, Type 2 | Phase 2 | Unknown | Tanta University | 70 | 2023-10-01 | 2023-08-25 |
| Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 100 | 2023-06-20 | 2023-06-12 |
| Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation Nitazoxanide 500Mg Oral Tablet, Rifaximin 550Mg Tab - Irritable Bowel Syndrome With Diarrhea | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2022-07-01 | 2025-07-14 | |
| Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19 Favipiravir, Nitazoxanide, Nitazoxanide Placebo - Covid19 | Phase 2 | Completed | Coordinación de Investigación en Salud, Mexico | 120 | 2021-10-12 | 2023-03-24 |
| Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™) - COVID-19 | Phase 2 | Recruiting | University of Oxford | 3800 | 2021-09-30 | 2026-02-19 |
| Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol - Covid19, Covid19 Drug Treatment | Phase 2 / Phase 3 | Unknown | ANRS, Emerging Infectious Diseases | 600 | 2021-04-12 | 2023-01-31 |
| COVID-19 Prophylaxis South Africa (COVER HCW) Nitazoxanide, Sofosbuvir/Daclatasvir - Covid19, SARS-CoV Infection | Phase 2 | Completed | University of Witwatersrand, South Africa | 1950 | 2020-12-08 | 2022-06-07 |
| A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 Nitazoxanide, Placebo Nitazoxanide, Ribavirin - SARS-CoV Infection, Covid19 | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 7 | 2020-12-02 | 2022-05-05 |
| The Nitazoxanide Plus Atazanavir for COVID-19 Study Nitazoxanide and atazanavir/ritonavir, Standard of Care - Covid-19 | Phase 2 | Terminated | Obafemi Awolowo University | 57 | 2020-10-09 | 2022-03-02 |
| Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19 Paracetamol, Artesunate-amodiaquine, Pyronaridine-artesunate - COVID-19 | Phase 2 | Completed | Shin Poong Pharmaceutical Co. Ltd. | 192 | 2020-09-03 | 2025-07-28 |
| Catalysing the Containment of COVID-19 Nitazoxanide, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | University of Cape Town | 322 | 2020-08-27 | 2022-08-16 |
| AGILE (Early Phase Platform Trial for COVID-19) CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide - Covid19 | Phase 1 / Phase 2 | Recruiting | University of Liverpool | 600 | 2020-07-03 | 2026-06-01 |
| Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients Nitazoxanide, Placebo - covid19 | Phase 2 / Phase 3 | Withdrawn | Azidus Brasil | 2020-07-01 | 2022-10-28 | |
| EAT-DUTA AndroCoV Trial Dutasteride 0.5 mg, Azithromycin, Nitazoxanide - Covid19 | Phase 2 / Phase 3 | Completed | Corpometria Institute | 138 | 2020-06-30 | 2021-01-28 |
Showing 20 of 56. Sign in to see all of them.
COVID-19 (17) · Hepatitis C, Chronic (8) · HIV Infections (5) · Coronavirus Infections (4) · Hepatitis C (4) · Colitis, Ulcerative (3) · Severe Acute Respiratory Syndrome (3) · AIDS-Related Opportunistic Infections (2) · Cryptosporidiosis (2) · Gastroenteritis (2) · Hepatic Encephalopathy (2) · Influenza, Human (2) · Rotavirus Infections (2) · Acute-On-Chronic Liver Failure (1) · Adenoviridae Infections (1)
Romark Laboratories L.C. (13) · Tanta University (6) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Azidus Brasil (2) · Telethon Kids Institute (2) · Universidade Federal do Rio de Janeiro (2) · ANRS, Emerging Infectious Diseases (1) · Ain Shams University (1) · Alexandria University (1) · Cairo University (1) · Coordinación de Investigación en Salud, Mexico (1) · Corpometria Institute (1) · Genfit (1) · Haydom Lutheran Hospital (1) · Juan Macías (1)
Egypt (14) · United States (12) · South Africa (5) · Brazil (4) · Australia (2) · Mexico (2) · Pakistan (2) · Thailand (2) · Argentina (1) · Burkina Faso (1) · Canada (1) · Guinea (1) · Haiti (1) · Laos (1) · Nepal (1)
Asem Elfert, MD (4) · Yehia El-Gohary, MD (3) · Arthur Berman, DO (2) · Ira Jacobson, MD (2) · Mona Abu-Zekry, MD (2) · Norman Gitlin, MD (2) · Patricia RM Rocco, MD, PhD (2) · Stephen Harrison, MD (2) · Ahmed Aijaz, MD (1) · Aijaz Ahmed, MD (1) · Alejandra Ramirez Venegas, M.D. (1) · Andy Goren, MD (1) · Arnold L Lentnek, M.D. (1) · Arturo Galindo Fraga, M.D. (1)
PMID 34473343, PMID 16829296, PMID 23890273, PMID 24852376, PMID 26640956, PMID 29982218, PMID 30753384, PMID 32071052, PMID 33188747, PMID 33397457, PMID 33602926, PMID 34450619, PMID 34582462, PMID 34699618, PMID 35271729, PMID 35492335, PMID 35869526, PMID 36160134, PMID 36272432, PMID 36435798, PMID 36574985, PMID 36803992, PMID 36963502, PMID 37261117, PMID 37382971, PMID 37470445, PMID 37778363, PMID 38225598, PMID 38677300, PMID 39032770, PMID 39896880, PMID 40385586, PMID 40815384, PMID 41082886, PMID 41232946, PMID 41321979, PMID 41848748, PMID 42177030, PMID 42309304